Guide Picker is a comprehensive design tool for visualizing and selecting guides for CRISPR experiments
- Soren H. Hough†1Email author,
- Kris Kancleris†1,
- Leigh Brody1,
- Neil Humphryes-Kirilov1,
- Joseph Wolanski1,
- Keith Dunaway1,
- Ayokunmi Ajetunmobi1 and
- Victor Dillard1
© The Author(s). 2017
Received: 22 November 2016
Accepted: 3 March 2017
Published: 14 March 2017
Guide Picker (https://www.deskgen.com/guide-picker/) serves as a meta tool for designing CRISPR experiments by presenting ten different guide RNA scoring functions in one simple graphical interface. It allows investigators to simultaneously visualize and sort through every guide targeting the protein-coding regions of any mouse or human gene.
Utilizing a multidimensional graphical display featuring two plots and four axes, Guide Picker can analyze all guides while filtering based on four different criteria at a time. Guide Picker further facilitates the CRISPR design process by using pre-computed scores for all guides, thereby offering rapid guide RNA generation and selection.
The ease-of-use of Guide Picker complements CRISPR itself, matching a powerful and modular biological system with a flexible online web tool that can be used in a variety of genome editing experimental contexts.
KeywordsCRISPR sgRNA RNA guide design software Cas9 Genome editing Functional genomics
CRISPR (clustered regularly interspaced short palindromic repeats) allows researchers to introduce site-specific mutations in a variety of organisms [1, 2]. SpCas9 (an RNA-guided nuclease found in Streptococcus pyogenes) is directed to target sites in the genome by a chimeric single guide RNA (sgRNA) . The sgRNA forms a complex with Cas9 and binds to genomic DNA according to a 20 bp protospacer sequence. The complex then induces a double-stranded break (DSB) three nucleotides upstream of the protospacer adjacent motif (PAM). The cell usually repairs the DSB through the endogenous non-homologous end joining (NHEJ) pathway which often produces insertion/deletion (indel) and potentially deleterious frameshift mutations . Customizing the 20 bp protospacer elements of the sgRNAs to target within and across different genes allows researchers to multiplex functional genomics experiments.
The PAM is essential for Cas9 binding. SpCas9 primarily recognizes NGG PAMs . Other PAMs, such as NAG, are referred to as non-canonical and have much lower rates of cleavage . However, although NAG is not as strong as NGG, SpCas9 may still cleave near NAG PAMs. Therefore, NAG PAMs are relevant when searching for off-target hits but are not desirable when designing highly active guides . SpCas9 also has tolerance for mismatches in the 20 bp protospacer element and can still induce DSBs despite a lack of full complementarity . In concert, variable PAM sequences and mismatch tolerance can lead to off-target edits (often via NHEJ) in unintended regions across the genome. These characteristics should be considered when predicting and analyzing off-target activity.
To ensure target specificity and guide activity, researchers depend on intelligent guide RNA design tools to predict guide RNA behavior . Several algorithms have already been released which use guide RNA sequences as predictors of both on- [7, 8] and off-target [4, 8] activity based on sequence composition. Additional algorithms focus on GC content , homopolymers  and other features. Existing online web tools frequently offer one or combine a few design considerations, but rarely aggregate all of these parameters in one place. This forces investigators to spend time comparing across multiple websites in order to guarantee optimal guide RNA design.
Guide Picker is also unique because it is the only online resource that allows guide design around all protein-coding transcripts of a gene. Transcripts are identified using Ensembl database annotations indicating known coding DNA sequences. Some design tools limit guide design to a 250 nucleotide input sequence while others only generate guides for a single transcript. By using all transcripts for a given gene, Guide Picker can offer more guide design options and help the user target as many transcript variants as possible to ensure gene knockout.
Guide sequences are determined by performing an exhaustive search throughout all protein-coding regions of the mouse or human genome based solely on available NGG SpCas9 PAM sites. This is accomplished using in-house Python scripts which, along with the scores, are contained in a Python wrapper to facilitate automation. This loading process occurs on a cloud-based web server and not on the user’s computer.
In addition to pre-loading guide sequences, Guide Picker further speeds up the CRISPR design process by pre-computing all scores for every guide RNA targeting coding genomic regions in the mouse and human reference genomes. For any given scoring function and gene, rendering all available guides takes fewer than five seconds (even for large genes with ~3000 guides, such as MUC4). Guide Picker displays all of these guides in an easily manageable graphical format that can be adjusted to improve visual accessibility.
Materials and methods
All Guide Picker scoring functions are based on previously published studies. Further, Guide Picker is free and accessible to the academic community on http://deskgen.com without restriction following sign-up. There is no paid version of Guide Picker. Moreover, the source code for Guide Picker at the time of publication is available in a GitHub repository at https://github.com/DeskGen/open-guide-picker under an open source MIT license. This includes access to the pre-computed guide score database associated with the tool.
Guide Picker uses the reference genomes for Mus musculus (GRCm38) and Homo sapiens (GRCh38) provided by Ensembl. This is because the scoring functions provided in the tool were developed with datasets from mammalian models and depended on standard U6 delivery plasmid systems. Therefore, all algorithms displayed by Guide Picker are constructed to make predictions within that context . Similarly, Guide Picker only uses SpCas9 guide RNA design rules. We made this decision because all guide RNA scoring algorithms to date were written to accommodate this nuclease and not its orthologs (e.g. NmCas9) which vary in PAM recognition, specificity and more.
The number of relationships between guide RNA data points can be explained by the formula n p (where n is a number of guides and p is a number of properties). The multidimensionality of guide RNA data yields an unwieldy number of variables for an investigator to navigate during the guide RNA design process. It also presents a challenge for creating a simple and efficient web tool UI. Guide Picker arose as a solution to this problem.
A previously trialed UI (https://www.deskgen.com/guidebook/advanced.html), where the user selected guides by manually navigating inside genes with a sequence browser, turned out to be an impractical, labor-intensive solution. In parallel, an internally used algorithm-assisted UI which presented the user with five top scoring guides for a given gene limited user engagement and control. It also stymied the user’s ability to cross-validate guides across multiple parameter thresholds.
To achieve maximum clarity and usability for this tool, a deliberate choice was made to adopt the minimalist design paradigm by reducing the subject to its principal components. This philosophy yielded a simple yet effective scatter plot graphic. The scatter plot allowed users to visualize and compare thousands of guides at once, thereby providing an intuitive UI for selecting guides that met specific scoring thresholds. It also offered more control over design than the algorithm-assisted UI.
However, any gains in clarity over previous UI iterations and peer web tools were outweighed by a reduction in data depth. The two-dimensional x/y view did not present a comprehensive method for selecting optimal guides. Also, a number of relationships between data points C(n, k) (where n is the number of properties and k is the number of axes) produced an unworkable UI. To compensate for this loss of dimensionality, we drew two scatter plots side-by-side, each displaying different properties for the same set of guides. The axis values of these two plots were user-selected guide design parameters. This improved readability while maintaining a robust level of customizable dimensionality.
We also chose to round score values to the nearest integer. Although floating numbers would provide a more continuous distribution of values, they are harder for users to read and compare. A decimal point is also likely to be statistically insignificant for choosing an optimal guide. Therefore, we decided to round score values as is consistent with other guide RNA design web tools [4, 8].
Due to the volume of guide RNA data and our decision to round score values to the nearest integer, highly dense overlapping regions became common in the scatterplots. In order to explore these dense regions more easily, we implemented a “Force Layout” view and “Fisheye” lensing (advanced Guide Picker features) to allow users to visualize overlapping guides or guides in close proximity to one another (Fig. 3). In concert, displaying all guides for a gene side-by-side across two plots according to four variable guide RNA scores offers unprecedented ease and control over guide design.
How to use Guide Picker
The scatterplots on Guide Picker depict every guide RNA available to target within the coding regions of the specified gene. Guide RNAs are organized by the x and y plot scoring variables determined by drop-downs underneath each scatterplot. Most scoring functions are continuous (from 0 to 100), but some are either stepped (0,10 … 90,100) or binary (0 or 100, true or false).
Percent peptide score
Representation refers to the proportion of the gene’s protein-coding transcripts a given guide RNA design can target. The stepped axis levels represent the percentage of targeted transcripts versus the total transcripts for that gene. This value is useful for designing guides against highly represented (consensus) exons. A graphical representation of how Transcript Representation is computed can be found in Fig. 4b. Plotting PPS against Transcript Representation in Guide Picker can be useful to determine the location of highly conserved transcripts in the context of the MCDS (Fig. 4c).
Specificity score (Hsu 2013)
The Hsu 2013 score predicts the specificity of the guide RNA. Off-target sites are evaluated based on genomic similarity to the guide RNA sequence. This evaluation takes into account mismatch number, position and density . It is important to note that while Hsu 2013 evaluates mismatch position and nucleotide number, it does not consider nucleotide identity (ATGC) .
Hsu 2013 considers both canonical NGG and non-canonical NAG PAM sites for SpCas9 . This information is accumulated into a continuous score from 0 to 100. A higher score indicates the guide is less likely to direct SpCas9 to cut at unintended (off-target) sites in the genome. A score of over 50 means the guide has no exact matches elsewhere in the genome, and a score of 100 represents maximum specificity.
On-target activity score (Doench 2014)
The Doench 2014 on-target activity score predicts the ability of the guide RNA to knock out the target gene . This score was developed based on a large-scale CRISPR experiment using 1841 guide RNAs saturating nine genes . The group investigated position-based nucleotide composition for guide RNAs with high versus low activity and constructed a scoring algorithm according to desirable/undesirable sequence traits . A score of 100 represents the highest predicted activity based on nucleotide sequence.
On-target activity (Doench 2016 full and positionless)
Like the Doench 2014 score, the Doench 2016 on-target activity score also predicts the ability of the guide RNA to knock out the target gene . This score is an improvement on Doench 2014 because it ranks data from multiple large-scale CRISPR experiments and combines their information to build a new algorithm with a more generalizable model . Once again, the group investigated the nucleotide composition of the guide RNAs and compared this data to activity . A score of 100 represents the highest predicted guide RNA activity based on nucleotide sequence. Guide Picker uses the latest version of the Doench algorithm available through the Azimuth GitHub (https://github.com/MicrosoftResearch/Azimuth).
Doench 2016 comes in two forms: Full and Positionless. The Doench 2016 Full score is adjusted based on the target location in the coding DNA sequence while the Doench 2016 Positionless score does not. This adjustment is based on the percent peptide score (PPS) which represents the progression through the CDS of that gene.
The reason to consider accounting for position in the CDS is that some studies have suggested that targeting in the 3′ end of the gene is less likely to lead to gene knockout , possibly due to nonsense-mediated decay . Therefore, Doench 2016 Full scores tend to be lower near the 3′ end of the gene. Conversely, Positionless does not penalize for targeting in the last third of the CDS.
Extreme GC content (low or high) can lead to poor or depleted guide RNA activity. The percentage of GC content refers specifically to the guide RNA protospacer element (not including the PAM). A recent study concluded that a range of 30–70% GC content yields optimal guide RNA activity . GC content is implemented in Guide Picker as a continuous score of 0–100%.
Four or more consecutive repeated nucleotides (homopolymers) in the guide RNA sequence have been shown to be detrimental to guide RNA activity . The homopolymer score in Guide Picker (“No Homopolymer”) yields a binary true/false output. A score of 100 means the guide RNA does not contain a consecutive 4+ nucleotide homopolymer (desirable) and a score of zero means it does contain a 4+ nucleotide homopolymer (undesirable).
Uracil triplets (UUU) score
The presence of a TTT DNA sequence (UUU in the RNA product) is detrimental to guide RNA activity because it is a terminator sequence for RNA Pol III transcription . Like the homopolymer score, the uracil triplet score in Guide Picker (“No UUU”) is binary. A score of 100 means the guide RNA does not contain any TTT sequences (desirable) and a score of zero means it does contain at least one TTT sequence (undesirable).
The microhomology score predicts the likelihood of creating an out-of-frame mutation via NHEJ-mediated repair . Regions of microhomology close to the cut site can facilitate indel formation, The higher the score, the more likely the guide RNA is to produce a frameshift-causing indel (desirable for knockout experiments).
Once the guide RNA designs have been filtered and selected, the Guide Picker-generated list can be saved for later use. The “Export & Save” button will download a .CSV report on all selected guides and store guide information in the My Projects tool (https://www.deskgen.com/my-projects/) at DESKGEN.com. The list is also text-selectable and can be copy-pasted by the user into a separate document (Fig. 2c).
The two plots in Fig. 5a illustrate how Guide Picker can be used to visualize key features of well-known scoring functions. The plot on the left compares the Doench 2016 Positionless on-target score with PPS, representing the location within the MCDS. Of note, there is no clear bias from Doench 2016 Positionless against guide scores at any position.
The plot on the right of Fig. 5a shows the same guides, but the y-axis displays Doench 2016 Full instead of Positionless. The downward trend toward a PPS of 100, or the 3′ end of the MCDS, demonstrates the bias of the Doench 2016 Full score. Doench 2016 Full operates under the assumption that guides targeting the 3′ end of the gene are less likely to induce gene knockout.
The difference between Full and Positionless is also made apparent in Fig. 5b. Correlating Doench 2016 Full and Positionless shows strong co-localization for many of the guide scores. However, some guides score much higher with Doench 2016 Positionless than they do with Full. Based on the relationships shown in Fig. 5a, it follows that the cluster of non-correlated guides would be located toward the 3′ end of the gene. We demonstrated this point by highlighting the non-correlated guide cluster in red in the plot on the left, which in turn showed the same guides with much lower Full scores toward 100% PPS on the right-hand plot.
Comparing Doench 2016 Full and Positionless in this way helps the user elucidate the difference between these two scores. Practically speaking, some investigators may want to avoid targeting the 3′ end of the gene and therefore will want to use Doench 2016 Full. Others may not rely on generalizations about the 5′ or 3′ end of the gene and instead will want to target 3′ proximal functional domains where appropriate in order to ensure gene knockout .
Guide Picker can also be used to demonstrate distributions for various scores by plotting parameters against themselves. In Fig. 5c, we compared Doench 2014 (left) and Doench 2016 Positionless (right) because they both avoid taking target location within the MCDS into account. Here we show that Doench 2014 tends to give guides a much lower score than Doench 2016 Positionless on average. We do so by highlighting about 1400 guides on the Doench 2014 plot which have lower Doench 2014 scores. With the Doench 2016 Positionless score, the distribution trends toward the middle of the plot. This is accentuated using the Force Layout feature (Fig. 5d).
Guide Picker can be used to design both gene knockout and tiling experiments using SpCas9. For gene knockout, the scoring parameters can be set to maximize guide efficiency. Ideally, this means selecting guides with a high Doench 2016 score, a high Hsu 2013 score, no homopolymers or uracil triplets, high transcript representation and a high microhomology score. Location in the MCDS (as indicated by the percent peptide score) will vary depending on the experiment.
First, guides are displayed in a PPS versus Doench 2016 Positionless on-target score plot. This is displayed in Fig. 6a using the human serotonin receptor 2A gene, HTR2A, as an example. We use Positionless in this example because we do not want to introduce scoring bias against guides targeting the 3′ end of the gene; 3′ regions may still be functional or essential. The guides can then be filtered according to a Doench 2016 Positionless threshold (e.g. 50) (Fig. 6b). The “Filtered Guides” list is now restricted to designs that target along the whole MCDS and that have a higher likelihood of on-target activity.
All guides above this threshold are then brought over to the right-hand plot and further narrowed down according to, for example, a relatively high Hsu 2013 off-target score (68, which is >50 and means they have no exact matches elsewhere in the genome) and a GC content range of 30–70%  (Fig. 6c). The final guide selection can be highlighted on the right to verify that they still target along the full length of the MCDS (as evidenced by a broad range of PPS values on the left-hand plot) (Fig. 6d).
In this example, the user now has 55 guides with convincing GC content, on-target scores and off-target scores that will direct SpCas9 across the entirety of the MCDS of HTR2A. These guide sequences can then be checked in the Knockout or Knockin tools (https://www.deskgen.com/guidebook/) or a comparable genome browser to determine their exact location in the transcript(s) or MCDS. From there, the user can execute the experiment using a small-scale library generated with the list from Guide Picker to elucidate the essentiality of each protein-coding region.
Guide Picker is the newest addition to the DESKGEN  (http://www.deskgen.com) cloud platform. It brings together ten literature-based guide RNA scoring parameters and functions. It is unique to other design tools because it can simultaneously visualize all guides for a given gene according to four pre-computed guide RNA design parameters at a time. The tool can be used to support various experimental applications by accelerating and improving the guide design process. As new scores are published, the tool will be updated to accommodate, utilize and compare the latest algorithms.
Clustered regularly interspaced short palindromic repeats
Master coding DNA sequence
Nonhomologous end joining
Protospacer adjacent motif
Percent peptide score
Single guide RNA
Streptococcus pyogenes Cas9
The authors would like to acknowledge Riley Doyle and Edward Perello at Desktop Genetics for their support and leadership in developing this tool and this manuscript.
All funding for this project was provided through Desktop Genetics Ltd. No external grants were used for the development of this tool.
Availability of data and materials
All algorithms are available from their source publications as referenced in the manuscript. The Guide Picker Github repository is available at https://github.com/DeskGen/open-guide-picker. The Azimuth Github repository can be found at https://github.com/MicrosoftResearch/Azimuth. The Vue.js Github repository can be found at https://github.com/vuejs/vue. The D3 Github repository can be found at https://github.com/d3/d3 while the quadtree Github can be found at https://github.com/d3/d3-quadtree. Further information is available from the corresponding author upon reasonable request.
SHH created all figures, wrote the majority of the text, edited, and shepherded the manuscript to completion. KK developed the Guide Picker tool and contributed to the Methods section of the manuscript. SHH and KK contributed to this manuscript equally. LB wrote the initial drafts and revisions of the paper and contributed to the conception and design of the manuscript. JW wrote initial drafts and revisions of the manuscript. NHK contributed to Percent Peptide and Transcript Representation figure and wrote the initial drafts and revisions of the manuscript. KD helped organize, edit and contribute to the Results section in a way that was critically important for the intellectual content of the manuscript. AA contributed intellectual content to the Discussions section of the manuscript. VD served as the executive lead on conception and development of the manuscript and gave final approval of the version to be published. All authors read and approved the final manuscript.
LB holds a PhD in biochemistry with a background in RNAi. NHK holds a PhD in molecular biology with a background in bioinformatics. AA holds a PhD in clinical medicine with a focus in neuroscience. KD is finishing a PhD program in integrated genetics with a background in bioinformatics. SHH has performed wet lab research and published in CRISPR biology. All authors have extensive experience with CRISPR from a bioinformatics and biological perspective.
All authors are employees of Desktop Genetics, Ltd.
Consent for publication
Ethics approval and consent to participate
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–21. doi:10.1126/science.1225829.Epub 2012 Jun 28.
- Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281–308. doi:10.1038/nprot.2013.143. PubMed PMID: 24157548, PubMed Central PMCID: PMC3969860, Epub 2013 Oct 24.View ArticlePubMedPubMed CentralGoogle Scholar
- Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol. 2015;33(5):538–42. doi: 10.1038/nbt.3190. Erratum in: Nat Biotechnol. 2016;34(2):210. PubMed PMID: 25798939; PubMed Central PMCID: PMC4618510.
- Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31(9):827–32. doi:10.1038/nbt.2647. PubMed PMID: 23873081, PubMed Central PMCID: PMC3969858, Epub 2013 Jul 21.View ArticlePubMedPubMed CentralGoogle Scholar
- Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, Aryee MJ, Joung JK. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol. 2015;33(2):187–97. doi:10.1038/nbt.3117. PubMed PMID: 25513782, PubMed Central PMCID: PMC4320685, Epub 2014 Dec 16.View ArticlePubMedGoogle Scholar
- Haeussler M, Schönig K, Eckert H, Eschstruth A, Mianné J, Renaud JB, Schneider-Maunoury S, Shkumatava A, Teboul L, Kent J, Joly JS, Concordet JP. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 2016;17(1):148. doi:10.1186/s13059-016-1012-2. PubMed PMID: 27380939, PubMed Central PMCID: PMC4934014.View ArticlePubMedPubMed CentralGoogle Scholar
- Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol. 2014;32(12):1262–7. doi:10.1038/nbt.3026. PubMed PMID: 25184501, PubMed Central PMCID: PMC4262738, Epub 2014 Sep 3.View ArticlePubMedPubMed CentralGoogle Scholar
- Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34(2):184–91. doi:10.1038/nbt.3437. PubMed PMID: 26780180, PubMed Central PMCID: PMC4744125, Epub 2016 Jan 18.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 system. Science. 2014;343(6166):80–4. doi:10.1126/science.1246981. PubMed PMID: 24336569, PubMed Central PMCID: PMC3972032, Epub 2013 Dec 12.View ArticlePubMedGoogle Scholar
- Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell. 2014;159(3):647–61. doi:10.1016/j.cell.2014.09.029. PubMed PMID: 25307932, PubMed Central PMCID: PMC4253859, Epub 2014 Oct 9.View ArticlePubMedPubMed CentralGoogle Scholar
- Popp MW, Maquat LE. Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine. Cell. 2016;165(6):1319–22. doi:10.1016/j.cell.2016.05.053. PubMed PMID: 27259145, PubMed Central PMCID: PMC4924582, Review.View ArticlePubMedGoogle Scholar
- Wu X, Scott DA, Kriz AJ, Chiu AC, Hsu PD, Dadon DB, Cheng AW, Trevino AE, Konermann S, Chen S, Jaenisch R, Zhang F, Sharp PA. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol. 2014;32(7):670–6. doi:10.1038/nbt.2889. PubMed PMID: 24752079, PubMed Central PMCID: PMC4145672, Epub 2014 Apr 20.View ArticlePubMedPubMed CentralGoogle Scholar
- Bae S, Kweon J, Kim HS, Kim JS. Microhomology-based choice of Cas9 nuclease target sites. Nat Methods. 2014;11(7):705–6. doi:10.1038/nmeth.3015.View ArticlePubMedGoogle Scholar
- Shi J, Wang E, Milazzo JP, Wang Z, Kinney JB, Vakoc CR. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat Biotechnol. 2015;33(6):661–7. doi:10.1038/nbt.3235. PubMed PMID: 25961408, PubMed Central PMCID: PMC4529991, Epub 2015 May 11.View ArticlePubMedPubMed CentralGoogle Scholar
- Munoz DM, Cassiani PJ, Li L, Billy E, Korn JM, Jones MD, Golji J, Ruddy DA, Yu K, McAllister G, DeWeck A, Abramowski D, Wan J, Shirley MD, Neshat SY, Rakiec D, de Beaumont R, Weber O, Kauffmann A, McDonald 3rd ER, Keen N, Hofmann F, Sellers WR, Schmelzle T, Stegmeier F, Schlabach MR. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. Cancer Discov. 2016;6(8):900–13. doi:10.1158/2159-8290.CD-16-0178. Epub 2016 Jun 3.View ArticlePubMedGoogle Scholar
- Hough SH, Ajetunmobi A, Brody L, Humphryes-Kirilov N, Perello E. Desktop Genetics. Per Med. 2016;13(6):517–21. doi:10.2217/pme-2016-0068.View ArticleGoogle Scholar